
|Videos|January 13, 2022
Mirvie RNA test aims to predict pregnancy complications
Author(s)Morgan Ebert, Managing Editor
Maneesh Jain, CEO and co-founder of Mirvie, a proprietary RNA platform that uses blood samples to predict pregnancy complications such as preeclampsia, sits down with Contemporary OB/GYN to discuss the potential of the test.
Advertisement
Newsletter
Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Restrictive abortion laws linked to increased EMTALA violations
2
FDA approves expanded use of flibanserin for hypoactive sexual desire disorder in women
3
Objective blood loss measures reveal higher postpartum hemorrhage rates
4
FDA clears FemVue Controlled for in-office tubal assessment
5









